Table 3.

The frequencies of the dendritic cell, monocyte, and basic peripheral blood lymphocyte subsets as well as the frequencies of these cell subsets expressing TLR2 antigen, for patients with endometriosis stage 1, 2, 3, and 4.

Parameter	Stage of the Disease (Mean + SD)				p-Value
	1	2	3	4
Myeloid dendritic cells BDCA1+CD19-	0.26 ± 0.21	0.34 ± 0.26	0.21 ± 0.11	0.29 ± 0.17	0.80
Plasmacytoid dendritic cells BDCA2+CD123+	0.41 ± 0.21	0.21 ± 0.14	0.32 ± 0.2	0.36 ± 0.22	0.09
Myeloid dendritic cells BDCA1+CD19−/Plasmacytoid dendritic cells BDCA2+CD123+ ratio	0.80 ± 0.68	1.9 ± 1.5	0.73 ± 0.18	1.0 ± 0.5	0.13
Classical monocytes CD14+CD16-	87.4 ± 3.1	87.1 ± 5.1	83.6 ± 3.5	81.9 ± 7.0	0.064
Non-classical monocytes CD14+CD16+	8.6 ± 4.2	9.5 ± 5.0	10.8 ± 2.7	13.7 ± 5.5	0.09
T lymphocytes CD3+ [%]	71.5 ± 4.6	73.1 ± 2.8	69.6 ± 6.1	71.8 ± 2.9	0.47
B lymphocytes CD19+ [%]	12.2 ± 3.2	11.1 ± 2.9	12.7 ± 3.3	10.5 ± 3.4	0.37
NK cells CD3-CD16+CD56+ [%]	11.2±5.8	9.9±3.8	10.5 ± 4.6	12.4 ± 2.9	0.54
NKT-like cells CD3+CD16+CD56+ [%]	2.4±2.1	3.1±3.0	2.7 ± 2.7	4.1 ± 3.5	0.56
T lymphocytes CD3+CD4+ [%]	41.7±6.7	39.8±3.9	36.3 ± 3.2	42.6 ± 7.2	0.076
T lymphocytes CD3+CD8+ [%]	28.0 ± 4.7	30.8 ± 5.2	31.6 ± 7.7	27.2 ± 4.4	0.28
T lymphocyte ratio CD3+CD4+/T CD3+CD8+	1.6 ± 0.5	1.3 ± 0.37	1.2 ± 0.39	1.6 ± 0.5	0.21
Myeloid dendritic cells BDCA1+CD19−TLR2+	12.0 ± 3.7	18.6 ± 6.4	27.3 ± 3.7	33.7 ± 7.1	<0.0001
Plasmacytoid dendritic cells BDCA2+CD123+ TLR2+	12.2 ± 8.9	12.1 ± 7.0	19.2 ± 9.4	13.1 ± 11.2	0.19
Classical monocytes CD14+CD16-TLR2+	6.5 ± 3.7	7.7 ± 4.2	11.5 ± 6.5	8.6 ± 4.7	0.38
Non-classical monocytes CD14+CD16+TLR2+	8.3 ± 3.3	14.2 ± 7.5	14.4 ± 15.2	9.4 ± 6.0	0.21
T lymphocytes CD4+TLR-2+ [%]	8.5 ± 12.3	7.7 ± 4.8	5.6 ± 6.5	3.9 ± 3.2	0.36
T lymphocytes CD8+TLR-2+ [%]	1.7 ± 1.4	8.3 ± 7.5	11.4 ± 21.2	10.6 ± 18.0	0.10
B lymphocytes CD19+TLR-2+ [%]	13.0 ± 6.4	5.0 ± 3.9	3.9 ± 3.1	2.5 ± 1.8	0.0007